Search

Abbott Laboratories

Cerrado

SectorSanidad

106.28 1.76

Resumen

Variación precio

24h

Actual

Mínimo

104.19

Máximo

106.71

Métricas clave

By Trading Economics

Ingresos

-149M

928M

Ventas

420M

13B

P/B

Media del Sector

38.989

50.373

BPA

1.42

Rentabilidad por dividendo

2.43

Margen de beneficios

7.369

Empleados

122,000

EBITDA

-1.3B

1.5B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+14.82% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

2.43%

2.12%

Próximas Ganancias

21 ene 2027

Fecha Próximo Dividendo

16 nov 2026

Próxima Fecha de Ex Dividendo

14 ene 2027

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1.4B

181B

Apertura anterior

104.52

Cierre anterior

106.28

Abbott Laboratories Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 oct 2026, 23:06 UTC

Abbott Laboratories shares are trading lower in after-market hours, despite a slight recovery, remaining below Friday's close.

29 oct 2026, 23:02 UTC

Abbott Laboratories shares advanced in after-market trading, supported by strength in the Health Care Equipment sub-sector, significantly above its 20-day moving average.

28 oct 2026, 23:02 UTC

Abbott Laboratories is advancing in after-market trading, reflecting notable strength since Wednesday's close, peaking at 1.43% before slightly retracing.

27 oct 2026, 23:01 UTC

Abbott Laboratories shares advanced in after-market trading, reaching their highest level since Tuesday's close amid strong new home sales data.

26 oct 2026, 23:11 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, reflecting a broader market decline that has persisted since Monday's close.

23 oct 2026, 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, experiencing notable volatility after shifting from slight gains to losses.

22 oct 2026, 23:51 UTC

Abbott Laboratories is gaining modestly in after-market trading, positioned significantly above its 20-day moving average and nearing the upper end of its one-month trading range.

21 oct 2026, 23:06 UTC

Abbott Laboratories shares are trading slightly higher in after-market hours, amid broader equity gains following a significant decline in U.S. crude oil inventories.

20 oct 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours, continuing a downward trend amid broader weakness in the Health Care Equipment sub-sector.

19 oct 2026, 23:41 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours after retracing from an early peak above Monday's close.

17 oct 2026, 00:01 UTC

Abbott Laboratories is trading modestly lower in after-market hours, retracing from a brief uptick earlier.

16 oct 2026, 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, following a brief rise earlier, amid ongoing volatility.

15 oct 2026, 23:06 UTC

Abbott Laboratories is trading lower in after-market hours, with cumulative returns dipping below Thursday's close after fluctuating during the session.

14 oct 2026, 23:31 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting strength as they trade above their 20-day moving average and near the upper end of their one-month range.

13 oct 2026, 20:08 UTC

Abbott Laboratories shares advanced, closing modestly above Monday's close, despite pulling back from an early session high during Tuesday's trading.

12 oct 2026, 23:06 UTC

Abbott Laboratories is trading higher in after-market hours, continuing a trend of three consecutive daily closes with slight upward movement since Monday's close.

10 oct 2026, 00:01 UTC

Abbott Laboratories is trading higher in after-market hours, marking the highest cumulative return since Friday's close and showing unusual strength within its one-month range.

9 oct 2026, 22:01 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

8 oct 2026, 22:45 UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

7 oct 2026, 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

6 oct 2026, 20:07 UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

5 oct 2026, 23:05 UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2 oct 2026, 20:07 UTC

Social Media
News

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

1 oct 2026, 20:07 UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

30 sept 2026, 20:07 UTC

News

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

29 sept 2026, 23:00 UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

25 sept 2026, 20:07 UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

24 sept 2026, 19:51 UTC

Macro Event

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

23 sept 2026, 20:01 UTC

News

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

22 sept 2026, 23:41 UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

Comparación entre iguales

Cambio de precio

Abbott Laboratories previsión

Precio Objetivo

By TipRanks

14.82% repunte

Estimación a 12 Meses

Media 121.938 USD  14.82%

Máximo 135 USD

Mínimo 115 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

19 ratings

17

Comprar

2

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat